tirzepatide semaglutide head to head beat in the first trial., 72 weeks: 20.2% of body weight lost vs 13.7%. Waist down about 18 cm vs 13 cm (DOI: 10.1056/NEJMoa2416394)., Why: semaglutide hits one Switching between weight-loss medications -

true safety depends on individual health, treatment history, and dosage

This review article is based on previously conducted studies and does not contain studies with human participants or animals performed by any of the authors

In most cases, this reaction does not usually repeat during the same round of antibacterial or antimicrobial treatments

This variation may relate to the causative organism: Type I infections are usually polymicrobial and seen in patients with multiple comorbidities, Type II infections are monomicrobial and often caused by Group A Streptococcus, and Type III is rare linked to specific geographic locations like Vibrio vulnificus

Lillys new data suggests the industry may now be entering the next phase of the obesity market: long-term maintenance strategies

Tomas, A., Futter, C